Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
about
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control studyTranslating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisAdvances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected childrenAlternative methods of diagnosing drug resistance--what can they do for me?Point-of-care diagnosis of tuberculosis: past, present and futureImpact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South AfricaThe Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosisThe prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem studyClinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnessesIs HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic reviewEpidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South AfricaComparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyUse of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosisThe impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort studyRifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV regionComparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in IndiaMolecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in BangladeshA multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimensQuantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South AfricaGenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-AnalysisBibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015)Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.Current developments and future perspectives for TB diagnostics.Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania.The future of molecular diagnostics for drug-resistant tuberculosis.Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian FederationGold on paper-paper platform for Au-nanoprobe TB detection.Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina FasoRapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South VietnamRapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technologyUse of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural UgandaThe value of laboratory tests in the diagnosis of tuberculosisLine probe assay for detection of Mycobacterium tuberculosis complex: An experience from Central India.High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda.
P2860
Q21144235-80C9CB5F-372A-4437-8BF3-009A989C1564Q26824812-206537FF-1502-43BC-ACBA-432F49E89D02Q26852073-43329220-9DDE-4485-A92E-BE78FB6C08D5Q26852644-A932AFFD-329B-4E79-A10E-387766FF6ECAQ27004667-5FDE79A9-642D-4FF6-82F1-FB0E9BEB1DEFQ28394564-397A7DB7-289C-49A2-B15D-BC5B1752949AQ28397729-DEEFE697-F596-44B6-ADDF-7DD7424C1685Q28474623-6D71B640-8826-4424-B31C-7A2276E1CB0BQ28474814-643EA518-3CB6-452F-B378-4B01439553F7Q28475509-C53602DF-D625-4172-B017-14BC34C44E0BQ28476143-A2E0F081-5030-46FB-A1E6-76BD084C1117Q28479276-134A6D8C-0B6B-4513-8909-B149678D8297Q28480576-9BFFCD68-E492-4BF3-9D23-7E48BC10E6B6Q28485439-298CE2A7-9E19-4357-BD3C-E395997072C3Q28534875-9F038495-C130-4AFC-A860-B951D5B625F7Q28536857-D821EB12-F116-4E8C-BEA1-CA8DB79A7B48Q28539727-47C594A6-3DCF-472E-9109-B9CAAE6BB0AEQ28539890-45C86DC7-266A-47E8-9C70-6A691C956E63Q28543642-9DE177EF-4F59-4F6B-8FFE-B770C1095F8FQ28544642-C4E3A4BF-D450-469D-9BF3-890AE15E8A43Q28550477-D3A60274-55EC-482C-A5C0-AED27ED59E91Q28555235-23FABC76-A67F-4D92-B5AD-0C0BFC339654Q30275673-734F5D5F-0199-4E3E-9B96-37F139FFD53CQ30397119-BC3DDBCB-5C5E-4F4B-B7E0-C3DDCBEF9FBFQ30410962-9151B25B-0CEC-40FB-8873-D09B864B60E9Q30426985-19B165E9-71B6-4E78-AC74-8B4DE86853ACQ30455525-E37E5EFB-64F9-40F5-AD25-143B6B5631DAQ33417860-95C57FE0-B9EA-4FC1-95F5-663F77F537EDQ33439092-741B58D8-67A8-4CAA-A9C8-BF8ADD3CC1A6Q33449024-5D540418-9C22-46F6-B21A-B679A25744D8Q33498127-8ADE0AF4-544D-4D2F-8B63-E5C120A87C5AQ33534845-219D445D-8E79-4A37-AEC5-2977BD42D4CFQ33582771-4A6B62B9-0FEB-4825-86A0-163E441A5ABDQ33595062-AA5F50EF-3A8B-47A2-8270-782ACB2A18FBQ33614228-A24E1EC0-11C7-48F0-B7C5-C3101D679AF1Q33651616-F503129D-5746-4A35-8D5F-8C0C0A81DCBEQ33693330-48FBD15A-1263-44F0-BF0A-0AAB9EA59F7AQ33768578-39DC3F3D-5438-4767-83E8-AE011DD0FE3AQ33804418-DA22D429-99EE-4EF1-9E22-90F31CCA3B5FQ33858850-93CE2132-5B51-42C9-80A8-5B39DC59D043
P2860
Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rapid molecular screening for ...... th laboratory in South Africa.
@en
Rapid molecular screening for ...... th laboratory in South Africa.
@nl
type
label
Rapid molecular screening for ...... th laboratory in South Africa.
@en
Rapid molecular screening for ...... th laboratory in South Africa.
@nl
prefLabel
Rapid molecular screening for ...... th laboratory in South Africa.
@en
Rapid molecular screening for ...... th laboratory in South Africa.
@nl
P2093
P2860
P921
P1476
Rapid molecular screening for ...... th laboratory in South Africa.
@en
P2093
Gerrit Coetzee
Heidi Albert
Marinus Barnard
Marlein E Bosman
Richard O'Brien
P2860
P304
P356
10.1164/RCCM.200709-1436OC
P407
P577
2008-01-17T00:00:00Z